Lipid management

Nearly two-thirds of patients with DM will die of coronary heart disease (CHD). Interventions targeting smoking cessation, glycemic control, blood pressure control, lipid management, antiplatelet therapy, and lifestyle changes, including diet and exercise, can reduce the risk of cardiovascular events. Patients with diabetes should receive at least an aspirin daily unless contraindicated. Refer to appropriate chapters in the text concerning CHD. 

NJ Stone, RO Bonow, M Gherorghiado, P Greenland, J Noble. Lipid management current diet and drug treatment options. Am J Med 101 40S-49S, 1996. 

List the direct and indirect and medical and nonmedical costs and outcome measures related to Alan Brouchard s diabetes education clinic and Carols lipid management program ... 

Renaud, S.C., Beswick, A.D., Fehili, A.N., Sharp, D.S., andElwood, P.C. 1992. Alcohol and platelate aggregation the Caerphilly prospective heart diseases study. Am. J. Clin. Nutr. 55, 1012-1017. Rivlin, R.S. 1998. Patient with hyperlipidemia who received garlic supplements. Lipid management. 

Both undertreatment and underutilization of medications are common problems in the elderly. It is often a result of stereotyping by healthcare professionals, lack of education of managing medications in the elderly, and lack of research. Examples include treatment of hypertension, prescribing hormone therapy, osteoporosis, treating MI, lipid management, pain management, and depression. 

The nature of the practice may be influenced by the availability of space in which to provide patient care. For example, the lack of facilities in which to meet privately with the patient may result in a telephone-based practice. Offering lipid management in the community pharmacy may require an investment in infrastructure. Some remodeling of the pharmacy may be needed to provide an area where confidential communications can occur. A lipid analyzer, as well as a dedicated clean area, must be supplied if blood lipid monitoring is to be offered. 

Pharmacists who practice lipid management should be familiar with dietary factors that influence lipids. If referrals to a dietician are allowed by law, the pharmacist should have a referral base from which to guide the patient. Handouts that describe the goals of fat content, specific foods to choose and avoid, and how to read and interpret food labels should be available for distribution. These are available from a variety of sources. Patients may be referred to the AHA web site, which offers information about recommended diets as well as recipes. Drug companies that market cholesterol-lowering medications often provide free patient information materials that may... 

Lipid analyzers are not necessarily a needed tool for providing lipid management services but can be very... 

Poley KA, Massing MW, Simpson RJ Jr, et al. Population impUcations of changes in lipid management in patients with coronary heart disease. Am J Cardiol 2004 93 193-195. 

Diabetes mellitus is considered to be a CHD-equi valent disorder therefore, the lipid management of diabetes patients is the same as that for patients with established vascular disease (American Diabetes Association, 1999). 

Problems within diabetes treatment can usually be divided into two phases, namely (i) acute and short-term treatment of patients and related to well-being and near-perfect physical abilities for professional and leisure activities, most often related to good metabolic control, (ii) On the other hand, the long-term perspective is preventive treatment of complications, both microvascular and vascular complications. Under special situations such as pregnancy, treatment is critical. A number of co-morbid situations are important heart disease (although not always specifically related to diabetes), obesity (an increasingly important problem), and lipid management (very common). Since 1991, we have seen a rapid development in the treatment of one important issue, namely treatment of erectile dysfunction, which is even more important in diabetic than in nondiabetic individuals. 

Assmann G. Pro and con High-density lipoprotein, triglycerides, and other lipid subtractions are the future of lipid management. Am J Cardiol 2001 87 2B-7B. 

Kwan BC, Kronenberg F, Beddhu S, et al Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 2007 18 1246-1261. 

Structures of drugs used for lipid management therapies [12]... 

---